June 2025 in “Basrah Researches Sciences” This article discusses how medicinal plants, known for their antiviral, immunomodulatory, antioxidant, and anti-inflammatory properties, may help alleviate long-term COVID-19 effects, but emphasizes the need for further clinical trials to confirm safety and efficacy.
December 2023 in “International journal of research publications” This review examines the potential of non-conventional therapies such as herbal medicine and nutraceuticals for treating post-COVID-19 syndrome, suggesting they may be promising but require further research.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study observed that over 60 days, Amalaki Churna, when administered to 30 patients with non-cicatricial hair fall, significantly reduced hair fall and improved hair tensile strength without adverse effects, suggesting beneficial Rasayana and Keshya properties.
September 2024 in “International Journal of Pharmaceutical Quality Assurance” This review suggests that Shirodhara, an ancient Ayurvedic therapy, may significantly improve mental well-being by reducing post-COVID anxiety, depression, and insomnia, although further randomized controlled trials are needed to confirm these promising findings.
January 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study reviews classical Ayurvedic texts and modern research on Amalaki, finding significant benefits for lipid profiles, blood glucose, and inflammation in clinical trials, while also suggesting potential benefits for liver, hair, skin, eyes, cognition, and respiratory health based on preclinical data and traditional claims.